Researchers Turn to Implantable Robots to Regenerate Tissue

The devices, which could one day treat children with esophageal atresia and short bowel, were recently tested in pigs.

Written byShawna Williams
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

PAGING DR. ROBOT: The esophagus-stretching device is connected by a cable to a battery-powered, wifi-capable controller.KARL PRICEParents from all over the world bring their babies and young toddlers to Boston Children’s Hospital for an operation that surgeon Russell Jennings wishes he didn’t have to perform. These children have been born with a disconnected esophagus, the upper section of which ends in a blind pouch a few centimeters from a lower portion that protrudes from the top of the stomach. The condition, called long-gap esophageal atresia, affects around one in 2,500 newborns, and is fatal if left untreated. But the procedure that Jennings and his colleagues currently perform to fix it, called the Foker process, takes its own toll.

To repair the digestive tract, Jennings makes an incision in the child’s back and stitches a few tiny sutures into the end of each of the two sections of esophagus. Then, he ties the sutures onto button-like wheels on the child’s back. The operation has to be conducted under anesthesia, and once it’s finished, depending on the particulars of the child’s condition, he or she may be kept sedated, on a ventilator, and fed intravenously for a few weeks to ensure the sutures stay in place. Every few days, Jennings or another doctor tightens the buttons a bit more, tugging at the sutures, until both sections of the esophagus grow long enough that they can reconnect to form a continuous tube.

Jennings estimates he’s performed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile

Published In

May 2018

Rare Diseases

The realities of studying uncommon conditions

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies